Growth Analyser Growth Analyser

Compare funds

Pick up to 10 funds. Compare funds from the same category for a fair reading.

Invesco India Business Cycle Fund · Direct ✕HDFC Pharma and Healthcare Fund · Direct ✕

Growth of ₹10,000

Basics

Invesco India Business Cycle FundHDFC Pharma and Healthcare Fund
CategorySectoral / ThematicSectoral / Thematic
PlanDirectDirect
Fund houseInvescoHDFC
NAV₹16.0500₹23.6750
NAV date20 Nov 202620 Nov 2026
History1.7 years3.1 years
Expense ratio0.8%1.1%
StarsNot rated★★★★★
Growth Score—94.50

Returns

Invesco India Business Cycle FundHDFC Pharma and Healthcare Fund
1 month+15.22%+12.97%
3 months+9.11%+7.13%
6 months+23.18%+17.84%
YTD+24.90%+33.73%
1 year+22.43%+32.20%
3 years (CAGR)—+30.70%
5 years (CAGR)——
10 years (CAGR)——
Since launch+33.66%+31.83%

Risk

Invesco India Business Cycle FundHDFC Pharma and Healthcare Fund
Volatility—15.8%
Downside volatility—8.5%
Sharpe—1.53
Sortino—2.86
Calmar—2.06
Return / risk—1.95
Deepest fall−16.01%−14.91%
Days to recover37126
Below its high+0.00%+0.00%

Against benchmark

Invesco India Business Cycle FundHDFC Pharma and Healthcare Fund
Alpha—+7.54%
Beta—0.97
R²—85.0%
Up capture—108.9%
Down capture—71.0%
Tracking error—6.1%
Information ratio—1.17
Treynor—0.24

Consistency

Invesco India Business Cycle FundHDFC Pharma and Healthcare Fund
Best 1-year+24.75%+67.01%
Middle 1-year+15.65%+23.25%
Worst 1-year+2.57%+1.71%
1-year periods with a loss0.0%0.0%
Middle 3-year—+30.22%
Positive months—72.2%
Best day+5.00%+3.18%
Worst day−4.37%−3.61%
Worst 5% day−1.65%−1.51%
Positive days53.2%58.3%
NAVs a year247247

SIP of ₹10,000 a month

Invesco India Business Cycle FundHDFC Pharma and Healthcare Fund
5-year XIRR——
5-year value——
3-year XIRR—+27.71%
1-year XIRR+38.00%+41.37%

Holdings overlap i

Overlap needs the monthly portfolio filing of at least two of these funds; not loaded yet.

Search Growth